MICHAEL PATRICK BOWEN

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry SCOTTSDALE, AZ NPI 1558771410

General Payments — all program years on this page

$2,687.25

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $335.40 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $335.4018

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $102.576
Lundbeck LLC $75.395
ITI, Inc. $61.373
JAZZ PHARMACEUTICALS INC. $60.592
Takeda Pharmaceuticals U.S.A., Inc. $20.961
HARMONY BIOSCIENCES LLC $14.521

By program year

Program yearAmountRecords
2022 $1,144.338
2023 $1,207.5214
2024 $335.4018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103355906 ABBVIE INC. $15.43 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103355908 ABBVIE INC. $16.88 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103355910 ABBVIE INC. $18.76 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103355912 ABBVIE INC. $13.61 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103355914 ABBVIE INC. $19.09 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103355916 ABBVIE INC. $18.80 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126056795 HARMONY BIOSCIENCES LLC $14.52 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137494144 Takeda Pharmaceuticals U.S.A., Inc. $20.96 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143197523 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.48 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143197527 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.38 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143197531 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.51 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145899532 Lundbeck LLC $16.30 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145899534 Lundbeck LLC $13.36 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145899536 Lundbeck LLC $15.56 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145899538 Lundbeck LLC $14.41 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145899540 Lundbeck LLC $15.76 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150221194 JAZZ PHARMACEUTICALS INC. $38.29 02/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150221196 JAZZ PHARMACEUTICALS INC. $22.30 01/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.